Spectrophotometric Method for the Estimation of Levosulpiride in Bulk Drug and Formulations

Authors

  • S. Shanmugam Adhiparasakthi College of Pharmacy, Melmaruvathur, Tamilnadu, India
  • Babu R. Adhiparasakthi College of Pharmacy, Melmaruvathur, Tamilnadu, India
  • Ravichandran V. Adhiparasakthi College of Pharmacy, Melmaruvathur, Tamilnadu, India

Abstract

Levosulpiride having D2-dopamine receptor antagonistic activity gives ant depressive and antiulcer effect. There are three new simple accurate, rapid, economical and precise procedures for spectrophotometric estimation of Levosulpiride in bulk and pharmaceutical formulation. Levosulpiride was estimated at 291.5 nm in 0.1 N NaOH, 290 nm in 0.1 N HCl and 292.5 nm in 6.8 phosphate buffer. Linearity range was found to be 10–50 µg/mL in all the three methods. The molar absorptivity was found to be 2.869 × 103/mol−1cm−1 in 0.1 N NaOH, 3.120 × 103/mol−1cm−1 in 0.1 N HCl and 3.135 × 103/mol−1cm−1 in 6.8 phosphate buffer. The methods were validated and can be successfully applied to estimate Levosulpiride in pharmaceutical dosage forms.

 

Keywords: Levosulpiride, Bulk Drug, Pharmaceutical Formulation, UV Spectrophotometry

Cite this Article:

Shanmugam S, Babu R, Ravichandran V.Spectrophotometric method for the estimation of Levosulpiride in bulk drug and formulations. Research & Reviews: A Journal of Drug Design & Discovery. 2015; 2(1): 19–23p.

Downloads

Published

2019-03-01

Issue

Vol. 2 No. 1 (2015)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.